Liu Jinbo, Li Tianrun, Huang Wei, Zhao Na, Zhao Hongwei, Wang Hongyu
Department of Vascular Medicine, Peking University Shougang Hospital, Beijing 100144, China.
Vascular Health Research Center of Peking University Health Science Center, Beijing, China.
Case Rep Vasc Med. 2022 Aug 23;2022:6867338. doi: 10.1155/2022/6867338. eCollection 2022.
Massive or submassive pulmonary embolism (PE) carries a high mortality. Percutaneous mechanical thrombectomy using the Angiojet system is accepted for the treatment of PE. Here, we reported two submassive PE cases who were treated with the Angiojet system successfully, to provide some advice for the therapy of submassive PE.
Two patients with suffocation were admitted to our hospital. One patient was accompanied by lower blood pressure (20% lower than basal blood pressure) and higher pulmonary artery pressure (89 mmHg); the other patient had larger right ventricular transverse diameter (46 mm), decreased left ventricular end diastolic anteroposterior diameter (34 mm), and higher heartbeats (107 heartbeats per minute). Pulmonary artery computed tomography angiography showed bilateral pulmonary embolism.
The Angiojet system with a high-pressure jet spray pattern (urokinase 25 wiu + sodium chloride injection 50 ml) was used. Intravascular thrombolysis by urokinase (100 wiu/day for 1 day) was done after being back in the ward. And low molecular weight heparin was used in hospitalization, and rivaroxaban was used after discharge. Both patients were treated successfully. However, the level of platelet was significantly lower in one patient after Angiojet system usage and recovered to the preoperative level the next day. Another patient suffered from bradyarrhythmias during the usage of Angiojet, and bradyarrhythmias disappeared when the Angiojet system stopped. Pulmonary embolism was cured after 3 months in both patients.
Angiojet could be a simple, safe, and well-tolerated treatment for massive or submassive PE. And hematocrit, platelet, kidney function, and heart rhythm should be monitored during perioperation.
大面积或次大面积肺栓塞(PE)的死亡率很高。使用Angiojet系统进行经皮机械血栓切除术已被用于治疗PE。在此,我们报告两例成功使用Angiojet系统治疗的次大面积PE病例,为次大面积PE的治疗提供一些建议。
两名因窒息入院的患者。一名患者伴有低血压(比基础血压低20%)和肺动脉高压(89mmHg);另一名患者右心室横径较大(46mm),左心室舒张末期前后径减小(34mm),心率较高(每分钟107次心跳)。肺动脉计算机断层扫描血管造影显示双侧肺栓塞。
使用具有高压喷射模式的Angiojet系统(尿激酶25万国际单位+氯化钠注射液50ml)。返回病房后进行尿激酶血管内溶栓(100万国际单位/天,共1天)。住院期间使用低分子肝素,出院后使用利伐沙班。两名患者均成功治疗。然而,一名患者在使用Angiojet系统后血小板水平显著降低,第二天恢复到术前水平。另一名患者在使用Angiojet期间出现缓慢性心律失常,当Angiojet系统停止使用时缓慢性心律失常消失。两名患者在3个月后肺栓塞均治愈。
Angiojet对于大面积或次大面积PE可能是一种简单、安全且耐受性良好的治疗方法。围手术期应监测血细胞比容、血小板、肾功能和心律。